Renaissance Technologies - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 1 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$431
-47.8%
139,374
-24.0%
0.00%0.0%
Q2 2023$825
+4.6%
183,300
+32.3%
0.00%0.0%
Q1 2023$789
-4.2%
138,500
+1.5%
0.00%0.0%
Q4 2022$824
-99.9%
136,500
-4.8%
0.00%0.0%
Q3 2022$948,000
+13.1%
143,400
-10.6%
0.00%0.0%
Q2 2022$838,000
+202.5%
160,486
+300.2%
0.00%
Q1 2022$277,000
-82.5%
40,100
-68.5%
0.00%
-100.0%
Q4 2021$1,584,000127,2000.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$287,436,0002.91%
Baker Brothers Advisors 10,123,824$289,845,0001.27%
Logos Global Management LP 400,000$11,452,0000.96%
Rock Springs Capital Management LP 382,359$10,947,0000.22%
HHLR ADVISORS, LTD. 583,333$16,701,0000.17%
Virtus ETF Advisers LLC 6,622$190,0000.08%
Jump Financial, LLC 13,700$392,0000.04%
ARS Investment Partners, LLC 7,400$212,0000.02%
FEDERATED HERMES, INC. 336,100$9,623,0000.02%
UBS ASSET MANAGEMENT AMERICAS LLC 1,287,735$36,867,853,0000.02%
View complete list of PRELUDE THERAPEUTICS INC shareholders